{"id":87223,"date":"2019-01-30T18:20:20","date_gmt":"2019-01-31T02:20:20","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2019\/01\/israeli-scientists-claim-theyre-on-the-path-to-a-cure-for-cancer"},"modified":"2019-01-30T18:20:20","modified_gmt":"2019-01-31T02:20:20","slug":"israeli-scientists-claim-theyre-on-the-path-to-a-cure-for-cancer","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2019\/01\/israeli-scientists-claim-theyre-on-the-path-to-a-cure-for-cancer","title":{"rendered":"Israeli Scientists Claim They\u2019re On The Path To A Cure For Cancer"},"content":{"rendered":"<p style=\"padding-right: 20px\"><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/israeli-scientists-claim-theyre-on-the-path-to-a-cure-for-cancer2.jpg\"><\/a><\/p>\n<p>Morad said in its infancy, AEBi was essentially \u201cdoing what everyone else was doing, trying to discover individual novel peptides for specific cancers.\u201d<\/p>\n<p>But then Morad and his colleague, <a href=\"http:\/\/www.aebi-bio.com\/content\/hanan-itzhaki-phd\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" data-ga-track=\"ExternalLink: http:\/\/www.aebi-bio.com\/content\/hanan-itzhaki-phd\">Dr. Hanan Itzhaki<\/a>, began attempting to identify why other cancer-killing drugs and treatments didn\u2019t work or eventually failed. And they say they\u2019ve found a way to counter that effect.<\/p>\n<p>Morad said most anti-cancer drugs attack a specific target on or in the cancer cell. \u201cInhibiting the target usually affects a physiological pathway that promotes cancer. Mutations in the targets \u2013 or downstream in their physiological pathways \u2013 could make the targets not relevant to the cancer nature of the cell, and hence the drug attacking it is rendered ineffective,\u201d he told <em>The Jerusalem Post.<\/em><\/p>\n<p><!-- Link: <a href=\"https:\/\/www.forbes.com\/sites\/robinseatonjefferson\/2019\/01\/29\/israeli-scientists-say-they-will-have-a-complete-cure-for-cancer-within-a-year\/\">https:\/\/www.forbes.com\/sites\/robinseatonjefferson\/2019\/01\/29...in-a-year\/<\/a> --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Morad said in its infancy, AEBi was essentially \u201cdoing what everyone else was doing, trying to discover individual novel peptides for specific cancers.\u201d But then Morad and his colleague, Dr. Hanan Itzhaki, began attempting to identify why other cancer-killing drugs and treatments didn\u2019t work or eventually failed. And they say they\u2019ve found a way to [\u2026]<\/p>\n","protected":false},"author":396,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-87223","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/87223","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/396"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=87223"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/87223\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=87223"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=87223"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=87223"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}